.5 CE (.25 pharm)
Learning Objectives:
Describe how vitamin D supplementation for reducing cancer risk or improving survival is supported by evidence for people with deficient or insufficient vitamin D blood levels, but is not supported among people with sufficient vitamin D blood levels.
State that vitamin D blood levels above about 35 ng/mL are linked to increased risks of prostate and lung cancer among men.
Develop a plan for assessing vitamin D levels among patients and prescribe supplements in accordance with research evidence of efficacy.
.5 CE (.25 pharm)
Learning Objectives:
Describe how vitamin D supplementation for reducing cancer risk or improving survival is supported by evidence for people with deficient or insufficient vitamin D blood levels, but is not supported among people with sufficient vitamin D blood levels.
State that vitamin D blood levels above about 35 ng/mL are linked to increased risks of prostate and lung cancer among men.
Develop a plan for assessing vitamin D levels among patients and prescribe supplements in accordance with research evidence of efficacy.